TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,067 | +46.2% | 260 | +95.5% | 0.00% | – |
| Q1 2024 | $4,835 | +211.9% | 133 | +101.5% | 0.00% | – |
| Q4 2023 | $1,550 | -40.2% | 66 | -54.8% | 0.00% | – |
| Q3 2023 | $2,594 | -1.7% | 146 | 0.0% | 0.00% | – |
| Q2 2023 | $2,638 | +103.7% | 146 | +41.7% | 0.00% | – |
| Q1 2023 | $1,295 | +29.5% | 103 | +106.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 50 | -50.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,089,856 | $35,778,000 | 4.39% |
| Vivo Capital, LLC | 2,262,200 | $38,729,000 | 4.28% |
| Cormorant Asset Management, LP | 1,971,422 | $33,751,000 | 2.36% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $30,602,000 | 2.36% |
| Sands Capital Ventures, LLC | 260,000 | $4,451,000 | 1.29% |
| COWEN AND COMPANY, LLC | 522,329 | $8,942,000 | 0.86% |
| RTW INVESTMENTS, LP | 2,023,179 | $34,637,000 | 0.80% |
| Perceptive Advisors | 1,296,416 | $22,194,000 | 0.64% |
| Ghost Tree Capital, LLC | 120,000 | $2,054,000 | 0.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $22,671,000 | 0.45% |